Details for Patent: 8,232,250
✉ Email this page to a colleague
Summary for Patent: 8,232,250
Title: | Low frequency glatiramer acetate therapy |
Abstract: | A method of alleviating a symptom of relapsing-remitting multiple sclerosis in a human patient suffering from relapsing-remitting multiple sclerosis or a patient who has experienced a first clinical episode and is determined to be at high risk of developing clinically definite multiple sclerosis comprising administering to the human patient three subcutaneous injections of a therapeutically effective dose of glatiramer acetate over a period of seven days with at least one day between every subcutaneous injection so as to thereby alleviate the symptom of the patient. |
Inventor(s): | Klinger; Ety (Tel Aviv, IL) |
Assignee: | Yeda Research & Development Co., Ltd. (Rehovot, IL) |
Application Number: | 13/308,299 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,232,250 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 8,232,250
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,232,250
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 077896 | ⤷ Try a Trial | |||
Argentina | 099078 | ⤷ Try a Trial | |||
Argentina | 121549 | ⤷ Try a Trial | |||
Argentina | 122567 | ⤷ Try a Trial | |||
Austria | 15421 | ⤷ Try a Trial | |||
Australia | 2010284666 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |